Table 3.
PICO and effects of the included SRs/MAs
| 1st author (year) | Intervention | Control | PSQI | Secondary outcomes | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| ISI | AIS | SOL | TST | WASO | NOA | SE | ||||
| SR and MA | ||||||||||
| Acupuncture | ||||||||||
| Cao (2009) [25] | Acupressure | Western medication | P | P | ||||||
| Cheuk (2012) [26] | G1: Acupuncture alone G2: Acupuncture alone G3: Acupuncture adjunctive to other treatment G4: Acupuncture adjunctive to other treatment |
G1: NT G2: Placebo or sham treatment G3: Other treatment alone G4: Placebo or sham treatment adjunctive to other treatment |
P | P | P | P | P | P | P | |
| Yeung (2012) [27] | Acupressure | Sham acupressure | P | P | ||||||
| Lan (2015) [28] | G1: Auricular acupuncture G2: Auricular acupuncture |
G1: Sham or placebo G2: Medications comparison |
P | P | P | P | P | |||
| Lee (2016) [30] | Acupressure | Drugs, Sham AT | P | P | P | |||||
| Shergis (2016) [31] | Acupuncture | Sham/placebo, standard pharmacotherapy | P | N | ||||||
| Choi (2017) [21] | G1: Acupuncture G2: Acupuncture G3: Acupuncture |
G1: Sham Acupuncture G2: Conventional drug G3: Hormone therapy |
P | |||||||
| Dong (2017) [24] | G1: Acupuncture G2: Acupuncture combined with western medicine G3: Electroacupuncture |
G1: Western medicine G2: Single medicine G3: Sham or placebo acupuncture |
pP | |||||||
| Huang (2017) [16] | G1: Acupuncture and/or moxibustion G2: Acupuncture and/or moxibustion combined with western medication or oral Chinese medicine |
G1: Common therapies (western drugs, sham acupuncture, oral Chinese medicine) G2: Same western medication or oral Chinese medicine |
P | |||||||
| Cao (2019) [33] | Acupuncture | NT, sham acupuncture, conventional therapy, western medication | P | P | P | |||||
| Liu (2019) [20] | Acupuncture | Sham acupuncture or conventional drugs | P | |||||||
| Zhao (2019) [18] | G1: APT G2: APT |
G1: Western medications G2: Sham APT and NT |
P | |||||||
| Kim (2019) [17] | Acupressure | Medications | P | |||||||
| Liu (2020) [38] | Acupuncture | Sham acupuncture | P | P | N | N | P | |||
| Zhang (2020) [41] | Acupuncture | Sham/placebo acupuncture or WL | P | P | N | P | P | P | ||
| Zhao (2020) [22] | Auricular acupressure | Any type of control group (including conventional western medicine, routine nursing, or blank control) | P | |||||||
| Mind and body practices | ||||||||||
| Rubio-Arias (2017) [32] | Exercise | Non-exercising controls | P | P | ||||||
| Feng (2019) [19] | Tui Na | Estazolam | pP | |||||||
| Wang (2019) [34] | Meditation, tai chi, qigong, and yoga, alone or in combination | Inactive (TAU or WL) and active (pharmacotherapy and CBT) control | P | P | U | P | N | U | ||
| Wang (2020) [40] | Mindfulness-based interventions | NT, WL, pharmacotherapy, SHE | P | P | N | |||||
| Natural products | ||||||||||
| Ni (2015) [29] | CHM, CHM combined with conventional therapies | Placebo, BZDs, non-BZDs, psychotherapy such as CBT and SHE | P | U | P | P | P | |||
| Zhang (2019) [35] | Chinese herbal medicine (CHM) | Placebo | P | P | P | P | P | |||
| Birling (2020) [36] | Zao Ren An Shen (ZRAS) | Conventional treatments, a placebo or no-treatment | pP | U | P | |||||
| Li (2020) [37] | TCM Yangxin Anshen Therapy (TYAT) | Placebo, BDZs | pP | P | P | N | P | |||
| Wang (2020) [39] | Chaihu Longgu Muli decoction (CLMD) monotherapy or CLMD plus conventional treatment | Placebo, NT, or conventional medicine | P | P | ||||||
| SR | ||||||||||
| Acupuncture | ||||||||||
| Yeung (2009) [42] | Traditional needle acupuncture (TNA) | Placebo, western medication, non-treated controls | P | P | P | U | ||||
| Sarris (2011) [43] | Acupuncture, acupressure | Sham, western medicine | pP | U | ||||||
| Wang (2017) [44] | HT7 stimulation | No HT7 stimulation, sham | P | P | ||||||
| Mind and body practices | ||||||||||
| Lowe (2019) [45] | Tai chi, exercise | A suitable, non-physically active control condition (i.e., non-/other intervention, WL) | pP | P | P | U | U | U | U | |
| Natural products | ||||||||||
| Sarris (2011) [43] | Tryptophan, Valerian, Kava | Placebo, diphenhydramine (active control) | U | U | U | U | U | |||
| Xie (2013) [23] | Suanzaoren decoction (SZRD) as a monotherapy or as an adjunct therapy to conventional medicine | Conventional medicine (BDZ), placebo, or NT | P | |||||||
Abbreviations: MA, meta-analysis; SR, systematic review; P, positive result; pP, partially positive result; N, negative result; U, uncertain result; PSQI, Pittsburgh Sleep Quality Index; ISI, Insomnia Severity Index; AIS, Athens Insomnia Scale; APT, auricular plaster therapy; SOL, sleep onset latency; TST, total sleep time; WASO, wake after sleep onset; NOA, number of awakenings; SE, sleep efficiency; CBT, cognitive behavioral therapy; CHM, Chinese herbal medicine; EC, education control; C, control group; NR, non-reported; NT, no treatment; RCT, randomized controlled trial; SHE, sleep hygiene education; TAU, treatment as usual; WL, wait list control.